The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019

Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004U.K.

This section has no associated Explanatory Memorandum

2.  The Medicines for Human Use (Clinical Trials) Regulations 2004 M1 are amended as follows.

Commencement Information

I1Reg. 2 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1

Marginal Citations